Bladder cancer institute awards $500,000 worth of research grants

The Johns Hopkins Greenberg Bladder Cancer Institute awarded a combined $500,000 to 10 bladder cancer projects.

The institute — established in 2014 as a collaborative initiative of Johns Hopkins Kimmel Cancer Center, Brady Urological Institute, and the Bloomberg School of Public Health and School of Medicine — is designed to advance the scientific understanding of bladder cancer and improve its treatment.

The institute awards grants of up to $50,000 each to encourage young investigators to pursue research that advances bladder cancer treatment. Grants, renewable for up to 3 years, are awarded in the areas of genetic and epigenetic approaches; targeted therapies; immunotherapy; patient care, prevention and screening; and pioneering studies.

This year’s grants fund six new projects and four renewed projects. Recipients are:

lCorinne Joshu, PhD, MPH, assistant professor of epidemiology at Johns Hopkins Bloomberg School of Public Health and assistant professor of oncology at Johns Hopkins Kimmel Cancer Center;

lMargaret Knowles, PhD, professor of experimental cancer research at University of Leeds, United Kingdom;

lAnirudha Singh, PhD, assistant professor of urology at Johns Hopkins University School of Medicine;

lAlexander Baras, MD, PhD, assistant professor of pathology and urology at Johns Hopkins University School of Medicine;

lShawn E. Lupold, PhD, associate professor of urology, oncology, and radiation oncology and molecular radiation sciences at Johns Hopkins University School of Medicine;

lMichael Johnson, MD, instructor of urology at Johns Hopkins University School of Medicine;

lTrinity Bivalacqua, MD, PhD, associate professor of urology, surgery and oncology at Johns Hopkins University School of Medicine and director of urologic oncology at Johns Hopkins Kimmel Cancer Center;

lGeorge Netto, MD, professor of pathology, urology and oncology at Johns Hopkins University School of Medicine;

lPeter O’Donnell, MD, assistant professor of medicine at University of Chicago; and

lArmine Smith, MD, assistant professor of urology at Johns Hopkins University School of Medicine.

For more information about funding opportunities, go to pilotprojects.onc.jhmi.edu.

The Johns Hopkins Greenberg Bladder Cancer Institute awarded a combined $500,000 to 10 bladder cancer projects.

The institute — established in 2014 as a collaborative initiative of Johns Hopkins Kimmel Cancer Center, Brady Urological Institute, and the Bloomberg School of Public Health and School of Medicine — is designed to advance the scientific understanding of bladder cancer and improve its treatment.

The institute awards grants of up to $50,000 each to encourage young investigators to pursue research that advances bladder cancer treatment. Grants, renewable for up to 3 years, are awarded in the areas of genetic and epigenetic approaches; targeted therapies; immunotherapy; patient care, prevention and screening; and pioneering studies.

This year’s grants fund six new projects and four renewed projects. Recipients are:

lCorinne Joshu, PhD, MPH, assistant professor of epidemiology at Johns Hopkins Bloomberg School of Public Health and assistant professor of oncology at Johns Hopkins Kimmel Cancer Center;

lMargaret Knowles, PhD, professor of experimental cancer research at University of Leeds, United Kingdom;

lAnirudha Singh, PhD, assistant professor of urology at Johns Hopkins University School of Medicine;

lAlexander Baras, MD, PhD, assistant professor of pathology and urology at Johns Hopkins University School of Medicine;

lShawn E. Lupold, PhD, associate professor of urology, oncology, and radiation oncology and molecular radiation sciences at Johns Hopkins University School of Medicine;

lMichael Johnson, MD, instructor of urology at Johns Hopkins University School of Medicine;

lTrinity Bivalacqua, MD, PhD, associate professor of urology, surgery and oncology at Johns Hopkins University School of Medicine and director of urologic oncology at Johns Hopkins Kimmel Cancer Center;

lGeorge Netto, MD, professor of pathology, urology and oncology at Johns Hopkins University School of Medicine;

lPeter O’Donnell, MD, assistant professor of medicine at University of Chicago; and

lArmine Smith, MD, assistant professor of urology at Johns Hopkins University School of Medicine.

For more information about funding opportunities, go to pilotprojects.onc.jhmi.edu.